Topic: Transcranial current stimulation

Epilepsy is a chronic neurological disorder that affects 1% of the world's population and is often linked with notable comorbidities and higher risks of mortality. Around 30% of epilepsies are considered pharmacoresistant (PRE). Resection surgery provides around remission in only 30-40% of eligible patients, leaving the remainder without alternative treatment options. Transcranial current stimulation (tCS) is a new safe and noninvasive approach that is increasingly being used in treating brain disorders. In the context of PRE, tCS seems to be a promising solution that aims to reduce cortical e